transcend-cll-004: pivotal in the fda approval of liso-cel for r/r cll
Published 2 months ago • 87 plays • Length 3:34Download video MP4
Download video MP3
Similar videos
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
1:16
transcend cll-004 update from eha: liso-cel for r/r cll
-
3:56
transcend-cll-004: liso-cel in cll
-
1:07
the current status of liso-cel in cll and updates from the transcend-cll-004 trial
-
4:20
extended follow-up of the transcend-cll-004 monotherapy cohort
-
3:17
treating cll in the uk: current and future outlooks
-
12:46
fixed duration treatment strategies in cll
-
4:02
living with chronic lymphocytic leukaemia (cll)
-
4:26
transcend-cll-004: lisocabtagene maraleucel in cll
-
5:03
understanding patient perspectives in cll treatment
-
3:14
understanding cll pathogenesis by assessing clonotypes
-
1:33
future advancements in the treatment of cll
-
1:29
the importance of treatment sequencing in cll
-
0:53
the future of cll treatment
-
1:28
the future of cll treatment
-
0:56
the current treatment landscape in cll
-
1:15
optimizing initial therapy of cll
-
1:04
the future of cll therapy
-
1:25
an insight into the future treatment landscape of cll
-
1:37
the importance of genomic testing in the diagnosis of cll
-
1:30
exciting new agents in cll